Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Phenytoin in Bisphosphonate-related Osteonecrosis of the Mandible
NCT03269214Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Sep 2012
- Primary completion
- Oct 2016
- Modality
- Small Molecules
01
Overview
Randomised, single-blind trial of phenytoin in Bisphosphonate-related osteonecrosis of the jaw (MRONJ) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Soft tissue healing at 12 months and Pain at 6 months. Started Sep 2012; status: completed.
02
Drugs
phenytoin
03
Conditions
Bisphosphonate-related osteonecrosis of the jaw (MRONJ)
Beyond the preview
Go deeper on NCT03269214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03269214.